| Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. | |
| | |
MedLine Citation:
|
PMID: 17714069 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Montelukast sodium (Singulair, Merck and Co., Inc., Whitehouse Station, NJ) is a selective and orally-active leukotriene receptor antagonist with demonstrated effectiveness for treating allergic asthma and allergic rhinitis in adults and children as young as 12 months of age for allergic asthma and 6 months of age for allergic rhinitis. It was recently approved in the US for prevention of exercise-induced bronchoconstriction in patients who are > or = 15 years of age. This paper updates a prior review of the data on the clinical efficacy of montelukast published in this journal. |
| | |
Authors:
|
William Storms |
Related Documents
:
|
23649799 - Effectiveness of an 8-week exercise programme on pain and specificity of neck muscle ac... 2943049 - Platelet activation during exercise induced asthma: effect of prophylaxis with cromogly... 2849339 - Enhanced generation of leukotriene b4 by neutrophils stimulated by unopsonized zymosan ... 23709519 - Does effectiveness of exercise therapy and mobilisation techniques offer guidance for t... 589779 - Ige, parasites and asthma in tanzanian children. 6398869 - The influence of prazosin on e. coli lipopolysaccharide-induced fever and noradrenaline... 17507789 - Analysis of alteration of blood pressure response to exercise through baroreflex. 487269 - Alterations in ventilation and gas exchange during exercise-induced carbohydrate deplet... 17720429 - Is previous thoracic sympathectomy a risk factor for exertional heat stroke? |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: Expert opinion on pharmacotherapy Volume: 8 ISSN: 1744-7666 ISO Abbreviation: Expert Opin Pharmacother Publication Date: 2007 Sep |
Date Detail:
|
Created Date: 2007-08-23 Completed Date: 2007-09-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100897346 Medline TA: Expert Opin Pharmacother Country: England |
Other Details:
|
Languages: eng Pagination: 2173-87 Citation Subset: IM |
Affiliation:
|
The William Storms Allergy Clinic, Colorado Springs, CO 80907, USA. sneezedoc@stormsallergy.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acetates
/
therapeutic use* Animals Anti-Asthmatic Agents / administration & dosage, therapeutic use Asthma / drug therapy* Asthma, Exercise-Induced / drug therapy Bronchoconstriction / drug effects* Humans Leukotriene Antagonists / administration & dosage, therapeutic use Quinolines / therapeutic use* Rhinitis, Allergic, Perennial / drug therapy* Rhinitis, Allergic, Seasonal / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Acetates; 0/Anti-Asthmatic Agents; 0/Leukotriene Antagonists; 0/Quinolines; 158966-92-8/montelukast |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Simvastatin: present and future perspectives.
Next Document: Lapatinib: a tyrosine kinase inhibitor with a clinical role in breast cancer.